Pasireotide Abbreviated Review - Veterans Affairs

Secondary endpoints included a UFC level < upper limit normal at months 3, 6, and 12, regardless of changes in dose; UFC > upper limit normal but decreased by > 50% of baseline (partial control of hypercortisolism); plasma corticotropin, UFC, serum and salivary cortisol levels over time; changes in clinical signs and symptoms; quality of life ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download